Decentralized Clinical Trials

Studies that are “performed using telemedicine and mobile/local healthcare practitioners, using processes and technologies different from the traditional clinical trial model,” are known as decentralized clinical trials (DCTs).

Rapid changes in clinical trial models enable us to provide you with fresh ideas that can improve patient recruitment, engagement, and retention while fostering continuity for your clinical study. A number of remote, mobile, and virtual features that are crucial in the realm of COVID-19, defining a new standard for how trials should be done, are available when you choose a CliniMed LifeSciences decentralized clinical trial (DCT) solution.

We use an enterprise strategy when designing and implementing DCTs in order to give you a fully integrated, technologically enhanced solution that lessens patient strain.

We are able to broaden the patient base and diversity, as well as speed delivery, thanks to the patient-centered design of our CliniMed LifeSciences DCT solutions. This helps us shorten the time it takes for novel pharmaceuticals, technologies, and therapies to reach the market.